Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, ...

The number of clinical trials in which AI designed or repurposed molecules, or targeted diseases, has more than doubled since ...

The acquisition of Anthos Therapeutics could be worth up to $3.1 billion and returns to Novartis a blood thinner it licensed ...

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

LIB Therapeutics Inc. (LIB), a privately-held, late-stage biopharmaceutical company today announced the U.S. Food and Drug Administration (FDA) has ac ...

The Esselen Award honors outstanding scientific achievement—including technical work—that contributes to public well-being and highlights the positive values of a chemistry profession. The award ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big ...

We recently compiled a list of the 30 Best and Worst Data Center Stocks. In this article, we are going to take a look at where Applied Digital Corp. (NASDAQ:APLD) stands against the other data center ...

In this article, we are going to take a look at where Applied Digital Corporation (NASDAQ:APLD) stands against the other AI stocks. AI continues to accelerate rapidly, moving from emerging ...

In a recent transaction, Wes Cummins (NYSE:CMI), CEO and Chairman of Applied Digital Corp. (NASDAQ:APLD), sold 200,000 shares of the company's common stock. The ...

As the pharma and biotech industries continue to embrace AI ... While the company lists typical sources for a healthcare product like this, such as payer data and APLD, it also sources data from blogs ...